BackOrphazyme A/S Overview

Orphazyme A/S Accounts Payable

Track Orphazyme A/S's accounts payable ($1.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.76M
1.51% YoYΔ $-27000.00 vs prior year quarter

Peer average

Loading

Orphazyme A/S Accounts Payable History

Loading

Orphazyme A/S vs. peers: Accounts Payable Comparison

Loading

Orphazyme A/S Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orphazyme A/S (ORPHY) FAQ

As of the most recent data (June 2024), ORPHY shows a accounts payable of $1.8M. That compares with $1.8M in the prior-year period — down 1.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORPHY's accounts payable is now $1.8M (was $1.8M) — a 1.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orphazyme A/S is outperforming or lagging.

Tracking ORPHY's accounts payable over time shows whether Orphazyme A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $1.8M That compares with $1.8M in the prior-year period — down 1.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Orphazyme A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1.8M) with ownership activity and broader fundamentals.

Orphazyme A/S's accounts payable is $1.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.